Chemotherapy-induced nausea vomiting Flashcards

1
Q

Three Elements of Emesis

A
  • Nausea –the sensation of the need to vomit. Subjective.
  • Retching –the synchronized spasmodic motion of the respiratory and abdominal muscles before or during vomiting.
  • Vomiting –the expulsion of gastric contents through the mouth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical presentation of N/V

A

Clinical Presentation

  • Increase saliva production
  • Increased skin temperature
  • Tachycardia
  • Unpleasant feeling, sick –stomach
  • “Queasy, butterflies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Negative Impact of CINV

A

Negative Impact of CINV

  • Dehydration
  • Malnutrition
  • Metabolic disturbances
  • Aspiration pneumonia
  • Esophageal rupture
  • Reduced functional capacity and quality of life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Causes of N/V

A

Drugs

1) Potassium
2) Anesthetics
3) NSAIDs and Opioids
4) Iron
5) Cytotoxic agents

Medical Conditions

1) Malignancies (CNS, GI)
2) Radiation
3) Hepatitis
4) Migraine
5) Pain
6) Hypercalcemia
7) Motility disorders
8) Morning sickness
9) Surgery
10) Anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathophysiology of CI-emesis

A

1) Chemotherapy acts on enterochromaffin cells of GI tract
2) causing them to secrete 5-HT and subsequent activation of 5-HT3 receptors on vagal afferents. This excitatory signal is then relayed to the NTS
3) The CTZ along with the nucleus of the solitary tract (NTS) and the dorsal motor nucleus of the vagus makes up the so-called dorsal vagal complex, which is the major termination site of vagal afferent nerve fibers.
4) The dominant receptors in this area are serotonin type 3 (5-HT3), dopamine type 2 (D2) and NK1.

5) CTZ then stimulates Vomiting center.
which has 5-HT3, Dopamine and NK1 receptors.

6) The “vomiting center” within the hindbrain, then precisely co-ordinate multiple autonomic reflexes that including
- excessive salivation,
- Increase respiratory rate
- inhibition of normal gastric motility, retroperistaltic activity in the duodenum and stomach,
- relaxation of the lower esophageal sphincter,
- tachycardia,
- sweating,
- breath holding
- contraction of abdominal and thoracic muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk for CINV

A
  • History of motion sickness
  • Anxiety
  • Low alcohol use Age: Younger than 30 (or 50) years old
  • Type, dose, and schedule of chemotherapy treatment

•History of pregnancy-associated emesis

  • History of poorly controlled emesis in a prior chemotherapy treatment
  • Age: Younger than 30 (or 50) years old
  • Gender: Females
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anticipatory CNIV

A

The day before Chemo

- can give BZD to tranquilize the pt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acute CNIV

A

1st 24 hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Delayed CNIV

A

24 - 120hr

2nd day to 5th day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Breakthrough

A

CINV that happens after using all possible means to prevent acute and delayed CINV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Selecting Anti-emetic Regimens for Chemotherapy Induced Emesis

A
  1. Chemotherapy agents are classified by their ability to cause nausea and vomiting.
  2. The emetogenicity of a chemotherapy regimen is based on the most emetogenicity drug within a regimen.
  3. Timing is the key (acute vs. delayed antiemetics)
  4. Account for patient specific risk factors. (clinical pearl)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

_____________, when combined with _________________ (for __________ cancer only), are designated as high emetic risk

when administered ___________

A

Anthracyclines, when combined with cyclophosphamide (for breast cancer only), are designated as high emetic risk

when administered IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Anthracyclines example

A
Daunorubicin
Doxorubicin
Epirubicin
Idarubicin
Valrubicin
Mitoxantrone
\_\_\_\_\_\_rubicin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ANTIEMETICS use in ACUTE Nausea and Vomiting:

A

AC = Anthracycline + cyclophosphamide

RISK Grp = Antiemetics required

  • HIGH non AC = 5-HT3 + DEX + NK1
  • HIGH AC = 5-HT3 + DEX + NK1
  • Carboplatin = 5-HT3 + DEX + NK1
    (HIGH RISK GRP)
  • Moderate (other than carboplatin) = 5-HT3 + DEX
  • Low = 5-HT3 OR DEX OR DOP
  • Minimal = NO PROPHYLAXIS
5-HT3 = serotonin 3 receptor antagonist 
DEX = Dexamethasone 

NK1 = neurokinin1 receptor antagonist such as APREPITANT or FOSAPREPITANT or ROLAPITANT or NEPA (combination of netupitant and palonosetron)

DOP = dopamine receptor antagonist

If the NK1receptor antagonist is not available for AC chemotherapy, palonosetron is the preferred 5-HT3receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In ___________ prophalaxis

If the NK1receptor antagonist is not available for AC chemotherapy, ____________ is the ______________antagonist

A

In acute CINV prophalaxis

If the NK1receptor antagonist is not available for AC chemotherapy, PALONOSETRON is the preferred 5-HT3receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Antiemetic use in DELAYEDNausea and Vomiting:

A

High Non-AC = DEX or (if APR 125mg for acute: (MCP + DEX) or (APR + DEX))

High AC = NONE or (if APR 125mg for acute: DEX or APR)

Carboplatin = NONE or (if APR 125mg for acute: APR)

Oxaliplatin or anthracycline or cyclophosphamide = DEX can be considered

moderate (other) / low/ minimal = NO routine prophylaxis

DEX = DEXAMETHASONE
MCP = METOCLOPRAMIDE
APR = APREPITANT
17
Q

___PITANT

A

NK1 receptor antagonist

eg aprePITANT or fosaprePITANT or rolaPITANT

18
Q

_____SETRON

A

5HT3 receptor antgonist

eg
ondanSETRON
graniSETRON
DolaSETRON

19
Q

Refractory Emesis

A

RefractoryEmesis

  • Need to re-evaluate risk, chemotherapy, tumor and concurrent disease
  • Try other unconventional agents: haloperidol, olanzapine
20
Q

Patient Education (Nutritional Tips)

  • •Diet Related:
A

•Diet Related:
–Eat small, frequent meals vs large meals
–Eat the largest meal when least nauseated
–Avoid your favorite foods (?) –> metallic taste
–Eat room temperature foods (less aroma)
–Avoid sweet, salty, spicy, fatty, or aromatic food,
–Avoid raw food, fruits with skin
–Do not eat for 1 to 2 hours before treatments if nausea occurs during treatments or within a few hours of treatment

21
Q

Patient Education (Nutritional Tips)

If experience CINV..

A

If experience CINV..

–Use shakes, or nutritional supplements
–Keep crackers or bread within reach
–Increase fluid intake
–Drink clear fluids, fruit juices: sip slowly
–Popsicles, jello, frozen fruit juices, ice chips are sources of fluid